t(4;11) (q21;q23) in acute myeloid leukemia-M0 following treatment [EW92 Protocol] for Ewing's sarcoma Leucemia mielóide aguda-M0 com t(4;11) (q21;q23) após tratamento para sarcoma de Ewing com o protocolo EW92

t(4;11) (q21;q23) in acute myeloid leukemia-M0 following treatment [EW92 Protocol] for Ewing's sarcoma Leucemia mielóide aguda-M0 com t(4;11) (q21;q23) após tratamento para sarcoma de Ewing com o protocolo EW92

We report on a 7-year-old girl with Ewing's Sarcoma (ES) who developed a poorly differentiated acute myeloid leukemia (AML-M0) 20 months after beginning the EW92 protocol for the treatment of the primary tumor. She received a total dose of 1500 mg of etoposide, a tumor cumulative radiation dose...

Full description

Bibliographic Details
Main Authors:	Terezinha J. Marques Salles, Márcia B. Costa, Vera L. L. Morais, Romualdo J. Filho, Mario H. Magalhães, Maria L. M. Silva, Sandra M. A. Silva, Maria S. Pombo de Oliveira
Format:	Article
Language:	English
Published:	Elsevier 2004-01-01
Series:	Revista Brasileira de Hematologia e Hemoterapia
Subjects:	Leucemia mielóide aguda secundaária translocação envolvendo a região 11q23 após uso de etoposídio Therapy-related acute myeloid leukemia MLL gene Ewing's sarcoma Topoisomerase II inhibitors G-CSF
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842004000200010

Similar Items

Previously Unreported Chromosomal Aberrations of t(3;3)(q29;q23), t(4;11)(q21;q23), and t(11;18)(q10;q10) in a Patient with Accelerated Phase Ph+ CML
by: Cigdem Aydin, et al.
Published: (2014-01-01)

Therapy-related acute lymphoblastic leukemia with t(4;11)(q21;q23) masqueraded as marrow lymphocytosis in a patient with breast cancer
by: Yen-Hsun Chen, et al.
Published: (2012-03-01)

Pathogenetic, Clinical, and Prognostic Features of Adult t(4;11)(q21;q23)/MLL-AF4 Positive B-Cell Acute Lymphoblastic Leukemia
by: F. Marchesi, et al.
Published: (2011-01-01)

<i>MLL</i>-Rearranged Acute Leukemia with t(4;11)(q21;q23)—Current Treatment Options. Is There a Role for CAR-T Cell Therapy?
by: Oliver Britten, et al.
Published: (2019-10-01)

Infant acute leukemia with lineage switch at relapse expressing a novel t(4;11)(q21;q23) MLL-AF4 fusion transcript
by: Ivanov Iuliu C., et al.
Published: (2013-03-01)

BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma.
by: Elizabeth T Wiles, et al.
Published: (2013-01-01)

Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma
by: David Herrero-Martin, et al.
Published: (2011-01-01)

Acute Lymphoblastic Leukemia with t(4;11)(q21;q23)/KMT2A-AFF1 Translocation: The Results of Allogeneic Hematopoietic Stem Cells Transplantation in Children and Adults
by: TL Gindina, et al.
Published: (2017-07-01)

B-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapy
by: Giovanni Carulli, et al.
Published: (2012-09-01)

EWS/FLI1 target genes and therapeutic opportunities in Ewing sarcoma
by: Florencia eCidre, et al.
Published: (2015-07-01)

GOOD OUTCOME FOR VERY HIGH RISK ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA CARRYING GENETIC ABNORMALITIES t(4;11)(q21;q23) or t(9;22)(q34;q11), IF PROMPTLY SUBMITTED TO ALLOGENEIC TRANSPLANTATION, AFTER OBTAINING A GOOD MOLECULAR REMISSION.
by: Matteo Parma, et al.
Published: (2015-05-01)

USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth
by: Maria E. Gierisch, et al.
Published: (2019-01-01)

Ecteinascidin 743 Interferes with the Activity of EWS-FLI1 in Ewing Sarcoma Cells
by: Patrick J. Grohar, et al.
Published: (2011-02-01)

Ewing sarcoma cells secrete EWS/Fli-1 fusion mRNA via microvesicles.
by: Masanori Tsugita, et al.
Published: (2013-01-01)

Molecular Analysis of the Ewing Sarcoma Protein (EWS) and the Survival Motor Neurone protein (SMN)
by: Shaw, Debra Jayne
Published: (2008)

Characterization of length-dependent GGAA-microsatellites in EWS/FLI mediated Ewing sarcoma oncogenesis
by: Johnson, Kirsten M.
Published: (2018)

EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma
by: Iniguez, Amanda Balboni, et al.
Published: (2019)

Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma.
by: Kirsten M Johnson, et al.
Published: (2017-01-01)

Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.
by: Kimberly Stegmaier, et al.
Published: (2007-04-01)

A zebrafish transgenic model of Ewing’s sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis
by: Stefanie W. Leacock, et al.
Published: (2012-01-01)

A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing’s sarcoma cells, interacts with the EWS-FLI1 and partner proteins
by: Krishna Priya Thangaretnam, et al.
Published: (2017-08-01)

A New Three-Way Translocation t(4;11;7)(q21;q23;q22) in a Mixed-Phenotype Acute Leukemia
by: Hirotaka Takasaki, et al.
Published: (2011-01-01)

Prenatal Diagnosis of a 4.9-Mb Deletion of 10q11.21 → q11.23 by Array Comparative Genomic Hybridization
by: Chih-Ping Chen, et al.
Published: (2010-03-01)

EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma.
by: Leah A Owen, et al.
Published: (2008-04-01)

Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development.
by: Claudio De Vito, et al.
Published: (2011-01-01)

Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing Sarcoma
by: Günther H.S. Richter, et al.
Published: (2020-01-01)

Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma
by: Patrick J. Grohar, et al.
Published: (2016-01-01)

Extraskeletal Ewing sarcoma of the parapharyngeal space with a unique translocation, t(19;22) (q13.4;q12.2)
by: Gloria Ramos-Rivera, et al.
Published: (2016-06-01)

The Constitutional Balanced Translocation t(11;22)(q23;q11.2)-An Indian Account
by: Vandana Kamath, et al.
Published: (2019-01-01)

HELICOBACTER PYLORI AND t(11;18)(q21;q21) TRANSLOCATION IN GASTRIC MALT LYMPHOMA
by: Karine Sampaio LIMA, et al.
Published: (2014-04-01)

SPOP and OTUD7A Control EWS–FLI1 Protein Stability to Govern Ewing Sarcoma Growth
by: Siyuan Su, et al.
Published: (2021-07-01)

Genomic EWS-FLI1 fusion sequences in Ewing sarcoma resemble breakpoint characteristics of immature lymphoid malignancies.
by: Manfred Berger, et al.
Published: (2013-01-01)

Acute myeloid leukemia with t(8;21)(q22;q22) preceded by breast granulocytic sarcoma Leucemia mielóide aguda com t(8;21)(q22;q22) precedido de sarcoma granulocítico na mama
by: Francisco D. Rocha Filho, et al.
Published: (2008-10-01)

Myelodysplastic/myeloproliferative neoplasm with t(2;11)(p21;q23)del(5) (q22;q33) but without mixed-lineage leukemia (MLL) rearrangement
by: Čolović Nataša, et al.
Published: (2021-01-01)

A Clinical and Molecular Description of a Rare Case of Chromosomal Abnormality (Partial Trisomy 14q11.2-q21.1 and Partial Monosomy 21q11.2-q21.3)
by: Grigory S. Vasilyev, et al.
Published: (2016-08-01)

Extra skeletal Soft Tissue Ewing’s Sarcoma with Variant Translocation of Chromosome t (4; 22) (q35; q12)-A Case Report
by: Prashanth Nagaraj, et al.
Published: (2013-10-01)

Prenatal diagnosis and molecular cytogenetic characterization of a proximal deletion of 22q (22q11.2→q11.21)
by: Chih-Ping Chen, et al.
Published: (2013-03-01)

Junction region of EWS-FLI1 fusion protein has a dominant negative effect in Ewing’s Sarcoma <it>in vitro</it>
by: Jully Babu, et al.
Published: (2012-11-01)

Rare case of a heterozygous microdeletion 9q21.11-q21.2: Clinical and genetic characteristics
by: Ivanov HY, et al.
Published: (2018-12-01)

High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition.
by: Ola Awad, et al.
Published: (2010-11-01)